BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 15314883)

  • 1. Preventing perinatal transmission of group B streptococcal disease.
    Freer J
    JAAPA; 2004 Mar; 17(3):47-50; quiz 51-2. PubMed ID: 15314883
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical inquiries. How should we manage infants at risk for group B streptococcal disease?
    Carlough MC; Crowell K; Richard N
    J Fam Pract; 2003 May; 52(5):406, 408-9. PubMed ID: 12737776
    [No Abstract]   [Full Text] [Related]  

  • 3. CDC issues recommendations for the prevention of perinatal group B streptococcal disease.
    Am Fam Physician; 1996 Oct; 54(5):1787-8, 1790, 1793. PubMed ID: 8857796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Group B streptococci and pregnancy. Strategies for the prevention of perinatal disease].
    Ungureanu V
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(3):145-52. PubMed ID: 19856854
    [No Abstract]   [Full Text] [Related]  

  • 5. Perinatal infection with Group B streptococci.
    Pettersson K
    Semin Fetal Neonatal Med; 2007 Jun; 12(3):193-7. PubMed ID: 17347062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group B streptococcus intrapartum prophylaxis guidelines adherence: a perinatal risk management issue.
    Hanson L; Vandevusse L
    J Perinat Neonatal Nurs; 2010; 24(2):100-3. PubMed ID: 20442605
    [No Abstract]   [Full Text] [Related]  

  • 7. Maternal screening strategy more effective than risk-based approaches for preventing group B streptococcal disease in neonates.
    Marsland T; King V
    J Fam Pract; 2002 Nov; 51(11):926. PubMed ID: 12485544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of perinatal group B Streptococcus disease in light of an unknown maternal carriage rate in Israel].
    Haimov-Kochman R; Bromiker R; Milwidsky A
    Harefuah; 2000 Jun; 138(12):1040-3. PubMed ID: 10979430
    [No Abstract]   [Full Text] [Related]  

  • 9. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis.
    Kriebs JM
    J Nurse Midwifery; 1998; 43(2):131-2. PubMed ID: 9581108
    [No Abstract]   [Full Text] [Related]  

  • 10. Group B strep update.
    Jonquil SG
    Midwifery Today Childbirth Educ; 1997; (42):30-1. PubMed ID: 9429431
    [No Abstract]   [Full Text] [Related]  

  • 11. Group B streptococcal disease in infants: progress in prevention and continued challenges.
    Verani JR; Schrag SJ
    Clin Perinatol; 2010 Jun; 37(2):375-92. PubMed ID: 20569813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Streptococcus agalactiae].
    Stronati M; Tzialla C; Lombardi G
    Pediatr Med Chir; 2003; 25(3):207-15. PubMed ID: 14601242
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing perinatal early-onset group B streptococcal infections. The new standard of care.
    Cardwell MS
    J Leg Med; 1997 Dec; 18(4):511-9. PubMed ID: 9433038
    [No Abstract]   [Full Text] [Related]  

  • 15. Compliance with a risk factor-based intrapartum prophylaxis program for neonatal group B streptococcal disease.
    McIlwaine K; Kneebone K; Barkehall-Thomas A; Wallace EM
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):199-201. PubMed ID: 16704472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlaboring patients with preterm premature rupture of membranes: duration of antimicrobial prophylaxis.
    Nassar AH; Usta IM
    Am J Obstet Gynecol; 2008 May; 198(5):609-10; author reply 610. PubMed ID: 18359470
    [No Abstract]   [Full Text] [Related]  

  • 17. Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention.
    Schrag SJ; Schuchat A
    Clin Infect Dis; 2004 May; 38(9):1209-11. PubMed ID: 15127329
    [No Abstract]   [Full Text] [Related]  

  • 18. Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(28):701-5. PubMed ID: 17637595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of early onset group B streptococcal disease: controversial issues.
    Tzialla C; Borghesi A; Garofoli F; Bollani L; Longo S; Stronati M
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():38-42. PubMed ID: 19718586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers--Connecticut and Minnesota, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(11):228-32. PubMed ID: 10763673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.